How Real-World Insights Can Improve The Future Of Personalized Medicine

By Theodore Leng, MD, MS, Verana Health

Data science and real-world evidence (RWE) play a transformative role in enhancing personalized medicine within ophthalmology and urology. Verana Health leverages high-quality real-world data (RWD) from established registries, such as the American Academy of Ophthalmology's IRIS Registry and the American Urological Association's AQUA Registry, to optimize patient outcomes and empower healthcare professionals. Through its innovative Qdata modules, Verana Health converts raw, de-identified RWD into tailored, research-ready datasets that facilitate early identification of at-risk patients in ophthalmology and support risk stratification and regulatory approvals in urology.

By fostering a seamless integration of research and clinical practice, Verana Health aims to deliver actionable insights that enhance treatment precision and care pathways. This approach underscores the potential of effectively harnessing RWD to create actionable RWE, propelling advancements in personalized medicine toward a more precise, efficient, and patient-centered future in healthcare.